Elevate Financial Statements From 2010 to 2024
| ELVUF Stock | USD 0.17 0.01 5.56% |
Check Elevate Uranium financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Elevate Uranium's main balance sheet or income statement drivers, such as , as well as many indicators such as . Elevate financial statements analysis is a perfect complement when working with Elevate Uranium Valuation or Volatility modules.
Elevate |
Elevate Uranium OTC Stock Shares Outstanding Analysis
Elevate Uranium's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Elevate Uranium Shares Outstanding | 275.5 M |
Most of Elevate Uranium's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Elevate Uranium is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, Elevate Uranium has 275.5 M of shares currently outstending. This is 84.81% lower than that of the Energy sector and significantly higher than that of the Uranium industry. The shares outstanding for all United States stocks is 51.82% higher than that of the company.
Elevate Uranium Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Elevate Uranium's current stock value. Our valuation model uses many indicators to compare Elevate Uranium value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Elevate Uranium competition to find correlations between indicators driving Elevate Uranium's intrinsic value. More Info.Elevate Uranium is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Elevate Uranium's earnings, one of the primary drivers of an investment's value.About Elevate Uranium Financial Statements
Elevate Uranium stakeholders use historical fundamental indicators, such as Elevate Uranium's revenue or net income, to determine how well the company is positioned to perform in the future. Although Elevate Uranium investors may analyze each financial statement separately, they are all interrelated. For example, changes in Elevate Uranium's assets and liabilities are reflected in the revenues and expenses on Elevate Uranium's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Elevate Uranium. Please read more on our technical analysis and fundamental analysis pages.
Elevate Uranium Ltd engages in the exploration and evaluation of uranium deposits. Elevate Uranium Ltd was incorporated in 1978 and is headquartered in West Perth, Australia. Elevate Uranium operates under Uranium classification in the United States and is traded on OTC Exchange.
Currently Active Assets on Macroaxis
Other Information on Investing in Elevate OTC Stock
Elevate Uranium financial ratios help investors to determine whether Elevate OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Elevate with respect to the benefits of owning Elevate Uranium security.